NEW JERSEY SOCIETY OF ONCOLOGY MANAGERS INC (EIN 223490371) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1997

Legal Domicile

Principal Officer

LINDA DEANGELIS

Phone

9082317552

Tax Period

2025-01-01 to 2025-12-31

NEW JERSEY SOCIETY OF ONCOLOGY MANAGERS INC, founded in 1997, is a small nonprofit in the Community Improvement sector that reported $212K in total revenue in fiscal year 2025. Revenue fell 41% from the prior year — a significant decline worth monitoring.

Mission

NEW JERSEY SOCIETY OF ONCOLOGY MANAGERS, INC., IS A NON-PROFIT CORPORATION FORMED TO ADDRESS THE EDUCATIONAL AND INFORMATION NEEDS OF ONCOLOGISTS AND HEMATOLOGISTS IN COMMUNITY PRACTICE IN NEW JERSEY.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $211,917

Investment Income $0

Other Revenue $0

TOTAL REVENUE $211,917

Expense Breakdown

Grants Paid $0

Salaries & Benefits $102,650

Fundraising Expenses $0

Program Expenses $194,977

Other Expenses $113,436

TOTAL EXPENSES $216,086

Year-over-Year Comparison

	2025	2024	Change
Revenue	$211,917	$362,182	-0.4%
Expenses	$216,086	$354,579	-0.4%
Net Income	$-4,169	$7,603	-1.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$102,650

Total Directors

$102,650

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DENISE JOHNSTONE	TREASURER	5.00	Officer Director	$47,550	$0	$47,550
LINDA DEANGELIS	PRESIDENT	5.00	Officer Director	$42,550	$0	$42,550
KIMBERLY LOEVY	SECRETARY	2.00	Officer Director	$12,550	$0	$12,550

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$211,917	$216,086	$255,133	$-4,169
2024	$362,182	$354,579	$259,302	$7,603
2023	$289,884	$237,924	$275,467	$51,960
2022	$356,184	$183,924	$220,873	$172,260
2021	$159,277	$145,213	$28,841	$14,064
2019	$275,936	$273,802	$25,996	$2,134
2018	$302,398	$379,878	$27,967	$-77,480

NEW JERSEY SOCIETY OF ONCOLOGY MANAGERS INC